Laura Willoughby, M.D.
NPI 1922426055 · Pulmonary Disease Physician · Vancouver, WA
Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1922426055
- Entity type
- Individual
- Primary specialty
- Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- Yes
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Student, Health Care
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
- Pulmonary Disease Physician207RP1001X
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
12 yrs in NPPES registry
- Profile completeness28% of score
83% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
410 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 75 | $126 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 59 | $16 |
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 56 | $178 |
| Critical Care, First 30-74 Minutes99291 | 42 | $206 |
| Test to Examine How Well the Lungs Exchange Gases94729 | 26 | $57 |
| Critical Care, Each Additional 30 Minutes |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 29 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Montelukast Sodium | 176 | 37 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 161 | 72 |
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 132 | 32 |
| Tiotropium Bromidebrand: Spiriva Respimat | 111 | 29 |
| Prednisone | 86 | 58 |
| Mometasone/Formoterolbrand: Dulera | 85 | 21 |
Practice location
Mailing address
Registry dates
- Enumerated
- 2014-04-05
- Last updated
- 2020-10-14
- Certified
- 2020-10-14
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.